2016
DOI: 10.1016/j.ygyno.2016.04.006
|View full text |Cite
|
Sign up to set email alerts
|

Health-related quality of life in ovarian cancer survivors: Results from the American Cancer Society's Study of Cancer Survivors — I

Abstract: Objective There are limited data on outcomes and predictors of health-related quality of life (HRQOL) of ovarian cancer survivors. Therefore, we examined the trajectory and predictors of HRQOL one- and two-years post-diagnosis in this population. Methods 365 ovarian cancer survivors, a subset of participants in the longitudinal American Cancer Society’s Study of Cancer Survivors-I, completed questionnaires at one-year post-diagnosis on sociodemographics, clinical factors, and HRQOL (SF-36). 284 women had HRQ… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
32
0
1

Year Published

2016
2016
2023
2023

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 40 publications
(34 citation statements)
references
References 39 publications
1
32
0
1
Order By: Relevance
“…Most research on cancer survivorship has been conducted in high-income settings where patients were more likely to receive a timely diagnosis, optimal treatment, follow-up, and survivorship care. Survival rates, therefore, differ drastically between countries but, regardless of setting, many cancer survivors experience symptom burden, loss of HRQoL, and (at least mild) psychological distress in the first year after treatment [12, 13, 36, 37]. Cancer stage is widely recognized as an important clinical determinant of HRQoL in cancer survivors [12, 19, 37–42].…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…Most research on cancer survivorship has been conducted in high-income settings where patients were more likely to receive a timely diagnosis, optimal treatment, follow-up, and survivorship care. Survival rates, therefore, differ drastically between countries but, regardless of setting, many cancer survivors experience symptom burden, loss of HRQoL, and (at least mild) psychological distress in the first year after treatment [12, 13, 36, 37]. Cancer stage is widely recognized as an important clinical determinant of HRQoL in cancer survivors [12, 19, 37–42].…”
Section: Discussionmentioning
confidence: 99%
“…Survival rates, therefore, differ drastically between countries but, regardless of setting, many cancer survivors experience symptom burden, loss of HRQoL, and (at least mild) psychological distress in the first year after treatment [12, 13, 36, 37]. Cancer stage is widely recognized as an important clinical determinant of HRQoL in cancer survivors [12, 19, 37–42]. A diagnosis of lung cancer and having comorbid conditions are also associated with a high symptom burden and low HRQoL [12, 13, 36, 37].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Moreover, all these aspects are prone to substantial variability, which may also be related to the instruments used for its evaluation. In a study from 2016 in women surviving ovarian cancer for at least 1 year, lower health-related QoL was associated with disease recurrence, treatment status, symptom burden, age, and number of comorbidities 21. A recent review noted that ovarian cancer survivors experience a wide range of sequelae that may persist for a lengthy time and negatively impact QoL 22…”
Section: Discussionmentioning
confidence: 99%
“…Factors such as disease stage at diagnosis and disease recurrence have been shown to impact QOL [2022]. However, evidence is mixed with some studies showing no association between clinical factors and QOL [23, 24].…”
Section: Introductionmentioning
confidence: 99%